Phaedra Chrousos
CIK 1774518 · View on SEC EDGAR ↗
First SEC filing: June 8, 2026 · Latest: June 8, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 14, 2021 | VNDA | S | 2,075 | $19.34 | $40,130 | 12,925 Direct | -13.83% | Disposed | -71.2% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 22, 2024 | VNDA | Stock Option (right to buy) | Common Stock (40,202) | $5.14 | May 21, 2034 | 40,202 | Acquired |
| June 8, 2023 | VNDA | Stock Option (Right to Buy) | Common Stock (33,960) | $6.50 | June 7, 2033 | 33,960 | Acquired |
| June 16, 2022 | VNDA | Stock Option (Right to Buy) | Common Stock (24,707) | $9.37 | June 15, 2032 | 24,707 | Acquired |
| June 10, 2021 | VNDA | Stock Option (Right to Buy) | Common Stock (10,000) | $19.21 | June 9, 2031 | 10,000 | Acquired |
| June 11, 2020 | VNDA | Stock Option (Right to Buy) | Common Stock (10,000) | $10.57 | June 10, 2030 | 10,000 | Acquired |
| June 13, 2019 | VNDA | Stock Option (Right to Buy) | Common Stock (10,000) | $15.04 | June 12, 2029 | 10,000 | Acquired |
| April 23, 2019 | VNDA | Stock Option (Right to Buy) | Common Stock (35,000) | $17.31 | April 22, 2029 | 35,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).